홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Abiraterone Acetate

HCID 9821849
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
154229-18-2
표준 SMILES
CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccnc4)=CC[C@@H]32)C1
InChIKey
UVIQSJCZCSLXRZ-UBUQANBQSA-N
분자식
C26H33NO2
평균 분자량
391.5 g/mol
단동위원소 질량
391.2511293

개요

Abiraterone acetate can cause developmental toxicity, female reproductive toxicity and male reproductive toxicity according to state or federal government labeling requirements.

이름 및 식별자

우선 이름
Abiraterone Acetate
IUPAC
[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
영어명
Abiraterone acetate
분자식
C26H33NO2
분자량
391.55

이름 및 동의어

Abiraterone acetate154229-18-2ZytigaCB7630YonsaCB-763017-(3-Pyridyl)-5,16-androstadien-3beta-acetate17-(pyridin-3-yl)androsta-5,16-dien-3beta-yl acetateDTXSID3049043EM5OCB9YJ6NSC-748121NSC-749227
이름 더 보기
(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetateABITATERONE ACETATEAbiraterone Acotate(3β)-17-(3-pyridinyl) androsta-5,16-dien-3-yl acetate(3)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol Acetate (Ester)(3beta)-17-(3-pyridinyl)-Androsta-5,16-dien-3-ol acetate (ester)[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetateCS-212
ABIRTEGAJNJ-212082AKEEGA COMPONENT ABIRATERONE ACETATEDTXCID4028969CHEBI:68639Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, acetate (ester), (3beta)-RefChem:57134BR9004

물성

구조 계산 물성

XLogP
5.2
극성 표면적
39.2 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
3
회전 가능 결합 수
3
무거운 원자 수
29
형식 전하
0
복잡도
739

실험 및 물리화학적 성질

DrugsPharmaceuticals -> Used in Switzerland
Human Drugs · 5건

FDA approved drugs -> Active ingredient

EMA approved medicines: Human medicine

EMA approved medicines: Human medicine

EMA approved medicines: Human medicine

FDA approved drugs -> Active ingredient

물리화학적 성질

녹는점
127 · 127-130°C
끓는 점
506.7 · 506.7±50.0 °C(Predicted)
밀도
1.14 · 1.14±0.1 g/cm3(Predicted)
저장 조건
-20 °C · -20°C
용해도
클로로포름(약간 용해됨), DMSO(약간 용해됨), 메탄올(약간 용해됨)
산도 계수 (pKa)
5.31 · 5.31±0.12(Predicted)
물리적 상태
가루
색상
흰색에서 베이지색
InChIKey
UVIQSJCZCSLXRZ-UBUQANBQSA-N
SMILES
C1[C@@]2(C)C(=CC[C@]3([H])[C@]2([H])CC[C@]2(C)C(C4=CC=CN=C4)=CC[C@@]32[H])C[C@@H](OC(=O)C)C1

화학적 성질

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 5건

This chemical does not meet GHS hazard criteria for 5.1% (2 of 39) of reports.

Danger

H302 (74.4%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P264, P270, P273, P280, P301+P317, P318, P319, P330, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 20 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Regulatory InformationHazard Traits - Developmental Toxicity; Reproductive Toxicity
Hazard Classes and CategoriesAcute Tox. 4 (74.4%)

독성 정보

Drug Induced Liver Injury · 6건

Drug Induced Liver Injury Rank (DILIrank 2.0)

Abiraterone acetate

vMost-DILI-concern

8

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

안전 데이터

wgk
3
rtecs
BV7992100
HS 번호
2937290000
Hazard Classifications
Aquatic Chronic 1Repr. 1BSTOT RE 2
스토리지 클래스
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects

화학 및 산업

약리 정보

FDA Pharmacological Classification · 2건

ABIRATERONE ACETATE

Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]

MeSH Pharmacological Classification · 3건

Substances that inhibit or prevent the proliferation of NEOPLASMS.

Compounds that bind to and inhibit enzymes involved in the synthesis of STEROIDS.

Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 ENZYMES.

응용 분야 · 2건

개요In April 2011, the United States FDA approved abiraterone acetate (CB7630) in combination with the steroid prednisone for the treatment of metastatic castration-resistant prostate cancer (mCRPC) for patients who were previously treated with a docetaxel containing regimen for late-stage disease. Abiraterone acetate affects prostate, testicular, and adrenal androgens by irreversibly inhibiting both the lyase and hydroxylase activity of cytochrome P450 17A (CYP17) signaling pathways (IC50's of 2.9 and 4 nM, respectively) thereby decreasing testosterone levels.Most common serious adverse events for abiraterone acetate versus placebo included fluid retention (30.5% vs. 22.3%), hypokalemia (17.1% vs. 8.4%), hypertension (9.7% vs. 7.9%), hepatic transaminase abnormalities (10.4% vs. 8.1%), and cardiac abnormalities (13.3% vs. 10.4%).

용도Abiraterone acetate is a novel steroidal inhibitor of human Cytochrome P450 (17α-Hydroxylase-C17,20-lyase): potential agent for the treatment of prostatic cancer.

상·하류 제품 정보

상류 원료

3-피리딘붕소산 피나콜 에스테르아비라테론

관련 반응

14건
반응 기록 만들기
HRID 53180 반응식
HRID 53180반응물로
HRID 53190 반응식
HRID 53190생성물로
HRID 525307 반응식
HRID 525307생성물로
HRID 525308 반응식
HRID 525308생성물로
HRID 525309 반응식
HRID 525309생성물로
HRID 525310 반응식
HRID 525310생성물로
HRID 525311 반응식
HRID 525311생성물로
HRID 531211 반응식
HRID 531211생성물로
이전1 / 2 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트

데이터베이스 식별자

CAS
154229-18-2
PubChem CID
9821849
DTXSID
DTXSID3049043
ChEMBL
CHEMBL271227
ChEBI
CHEBI:68639
UNII
EM5OCB9YJ6
EC Number
620-314-7
Nikkaji
J617.458B

Off-White Solid

(3β)-Androsta-5,16-diene-3,17-diol 3-Acetate 17-(Trifluoromethanesulfonate)
3-Pyridylboronic acid
디에틸(옥시-피라질)보란
3-브로모피리딘
Dehydroepiandrosterone acetate
추가 설명 · 1건

정의ChEBI: A sterol ester obtained by formal condensation of the 3-hydroxy group of abiraterone with the carboxy group of acetic acid. A prodrug that is converted in vivo to abiraterone. Used for treatment of metastatic castrate-resistant prostate cance .